Latest News

Latest News

News from the World Hepatitis Alliance

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Interested in leading a global organisation in the fight to eliminate viral hepatitis?

15 Sep 2016 Bridie Taylor

The World Hepatitis Alliance (WHA) is seeking nominations for two key offices; President-Elect and Regional Executive Board Members, to drive action...

Europe Adopts Regional Action Plan to Eliminate Viral Hepatitis

14 Sep 2016 Tara Farrell

Today, representatives from the 53 countries in the WHO European Region adopted the first-ever Action Plan for viral hepatitis. The Action Plan,...

CHANGE OF DATE: WORLD HEPATITIS SUMMIT 2017

12 Sep 2016 Tara Farrell

Due to unforeseen circumstances, the Committee of the World Hepatitis Summit - comprising the World Hepatitis Alliance; World Health Organization and...

100 ACTIVISTS STAGE A “DIE-IN” TO SEND A POWERFUL MESSAGE TO WORLD LEADERS TO ELIMINATE VIRAL HEPATITIS

28 Jul 2016 Tara Farrell

On World Hepatitis Day, the World Hepatitis Alliance and The Hepatitis C Trust, held the first hepatitis “die-in” at Piccadilly Circus in London to...

Globally, 95% of people living with a cancer-causing illness are unaware

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in viral hepatitis testing to reduce liver cancer deaths...

Treatment of hepatitis C has more than doubled since 2013. Yet 99% of people are still being denied the life-saving cure

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in testing and treatment across all countries to reduce the...

Viral hepatitis is the 7th leading killer worldwide, killing more people than HIV, TB or malaria

7 Jul 2016 Tara Farrell

Viral hepatitis has become the seventh leading cause of death and disability in the world, killing more people in a year than HIV/AIDs, tuberculosis...

WHA presents Knowledge for Change webinar series to enhance hepatitis knowledge

8 Jun 2016 Bridie Taylor

Advocacy is a powerful tool but in order to effectively advocate and bring about change, it is important to first build our knowledge in key areas...

Governments on track to eliminate viral hepatitis by 2030

28 May 2016 Tara Farrell

194 Member States commit to eliminating viral hepatitis at World Health Assembly On 28 May, 194 Member States made a historic commitment to eliminate...

A make-or-break moment for the first viral hepatitis strategy

26 May 2016 Tara Farrell

REPOSTED FROM DEVEX : By Jenny Lei Ravelo @JennyLeiRavelo Six years ago, advocates against viral hepatitis experienced a huge win: Member states at...

7.1 million lives to be saved if governments agree to eliminate global killer

24 May 2016 Bridie Taylor

The World Hepatitis Alliance is calling on 194 Member States to support the adoption of the World Health Organization’s first ever Elimination...

Animated video launched to help support the adoption of WHO’s Viral Hepatitis Strategy at the World Health Assembly

23 May 2016 Tara Farrell

To coincide with the 69th World Health Assembly, the World Hepatitis Alliance has launched an animated video to showcase the importance of WHO’s...

World Hepatitis Alliance supports UK member in fight for patient rights

19 May 2016 Tara Farrell

The World Hepatitis Alliance is supporting The Hepatitis C Trust, a UK based charity, in their law-suit against National Health Service (NHS) England...

Pages

News from infohep

RNA interference therapy lowers viral biomarker in people with hepatitis B

14 Dec 2017 Liz Highleyman
ARB-1467, a novel type of treatment for hepatitis B, reduced levels of hepatitis B surface antigen (HBsAg) when used alone, and it may play a role in...

Immune modulator inarigivir looks promising for people with hepatitis B

12 Dec 2017 Liz Highleyman
Inarigivir, or SB 9200, an immune-modulating drug that has a dual mechanism of action against hepatitis B virus (HBV), reduced levels of HBV DNA, RNA...

TAF for hepatitis B improves kidney function and bone loss

30 Nov 2017 Liz Highleyman
Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies...

REP 2139 combination therapy leads to functional control of hepatitis B virus

29 Nov 2017 Liz Highleyman
A majority of people with chronic hepatitis B treated with a nucleic acid polymer (REP 2139 or REP 2165) plus tenofovir and pegylated interferon were...

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

28 Nov 2017 Liz Highleyman
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in...

US approves new hepatitis B vaccine as public health agencies update guidelines

27 Nov 2017 Liz Highleyman
On 9 November the US Food and Drug Administration (FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of...

Model shows hepatitis C treatment is cost-effective in Japan

27 Nov 2017 Liz Highleyman
Treatment of chronic hepatitis C with direct-acting antivirals (DAAs) can lead to substantial savings by preventing the development of liver failure...

More work and lower drug prices are needed to eliminate hepatitis C worldwide

27 Nov 2017 Liz Highleyman
Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and...

Nivolumab improves outcomes in liver cancer study

13 Nov 2017 Liz Highleyman
Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease...

High rate of hepatitis C reinfection in German men who have sex with men

3 Nov 2017 Keith Alcorn
Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to...